ProFund Advisors »

Monte Rosa Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $395k 25k 15.68

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Netflix (NFLX)
Palantir Technologies Cl A (PLTR)
Cisco Systems (CSCO)
Costco Wholesale Corporation (COST)

View all positions for ProFund Advisors

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics